Lion Point Capital’s Milestone Pharmaceuticals MIST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.06M | Hold |
548,806
| – | – | 7.23% | 7 |
|
|
2025
Q1 | $439K | Sell |
548,806
-477,000
| -47% | -$382K | 2.8% | 15 |
|
|
2024
Q4 | $2.42M | Sell |
1,025,806
-628,348
| -38% | -$1.48M | 12.68% | 2 |
|
|
2024
Q3 | $2.51M | Sell |
1,654,154
-686,053
| -29% | -$1.04M | 5.6% | 4 |
|
|
2024
Q2 | $3.09M | Buy |
2,340,207
+40,000
| +2% | +$52.8K | 5.63% | 3 |
|
|
2024
Q1 | $4.12M | Buy |
2,300,207
+650,000
| +39% | +$1.16M | 2.3% | 3 |
|
|
2023
Q4 | $2.76M | Buy |
1,650,207
+1,200,000
| +267% | +$2M | 1.38% | 4 |
|
|
2023
Q3 | $1.4M | Hold |
450,207
| – | – | 0.62% | 10 |
|
|
2023
Q2 | $1.28M | Buy |
450,207
+25,000
| +6% | +$71.3K | 0.58% | 11 |
|
|
2023
Q1 | $1.68M | Hold |
425,207
| – | – | 0.69% | 17 |
|
|
2022
Q4 | $2.89M | Sell |
425,207
-1,132,026
| -73% | -$7.7M | 0.41% | 16 |
|
|
2022
Q3 | $11.2M | Buy |
1,557,233
+608,663
| +64% | +$4.37M | 2.46% | 9 |
|
|
2022
Q2 | $5.63M | Buy |
948,570
+265,000
| +39% | +$1.57M | 0.64% | 19 |
|
|
2022
Q1 | $4.39M | Buy |
+683,570
| New | +$4.39M | 1.02% | 18 |
|